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Water-soluble Niemann-Pick C2 (NPC2) and
membrane-bound NPC1 are cholesterol-binding
lysosomal proteins required for export of lipopro-
tein-derivedcholesterol from lysosomes. Thebinding
site in NPC1 is located in its N-terminal domain (NTD),
which projects into the lysosomal lumen. Here we
perform alanine-scanning mutagenesis to identify
residues in NPC2 that are essential for transfer of
cholesterol to NPC1(NTD). Transfer requires three
residues that form a patch on the surface of NPC2.
We previously identified a patch of residues on the
surface of NPC1(NTD) that are required for transfer.
We present a model in which these two surface
patches on NPC2 and NPC1(NTD) interact, thereby
opening an entry pore on NPC1(NTD) and allowing
cholesterol to transfer without passing through the
water phase. We refer to this transfer as a hydro-
phobic handoff and hypothesize that this handoff is
essential for cholesterol export from lysosomes.INTRODUCTION
Low-density lipoproteins (LDLs) and related plasma lipopro-
teins deliver cholesterol to cells by receptor-mediated endocy-
tosis. The lipoprotein is degraded in late endosomes and lyso-
somes where its cholesterol is released (Brown and Goldstein,
1986). Egress of cholesterol from late endosomes and lyso-
somes (hereafter referred to as lysosomes) requires two pro-
teins: Niemann-Pick C2 (NPC2), a soluble protein of 132 amino
acids (Naureckiene et al., 2000); and NPC1, an intrinsic
membrane protein of 1278 amino acids and 13 postulated
membrane-spanning helices that span the lysosomal mem-
brane (Pentchev et al., 1995; Carstea et al., 1997). Recessive
loss-of-function mutations in either NPC2 or NPC1 produce
NPC disease, which causes death in childhood owing to
cholesterol accumulation in lysosomes of liver, brain, and lung
(Pentchev et al., 1995).166 Cell Metabolism 12, 166–173, August 4, 2010 ª2010 Elsevier IncIn keeping with their cholesterol export role, NPC2 and
NPC1 both bind cholesterol (Xu et al., 2007; Infante et al.,
2008a). Competitive binding studies (Infante et al., 2008b) and
crystal structures (Xu et al., 2007; Kwon et al., 2009) indicate
that the two proteins bind cholesterol in opposite orientations.
NPC2 binds the isooctyl side chain, leaving the 3b-hydroxyl
exposed, whereas NPC1 binds the 3b-hydroxyl, leaving the
side chain partially exposed. The cholesterol-binding site on
NPC1 is located in the NH2-terminal domain (NTD), which
projects into the lysosomal lumen. This domain, designated
NPC1(NTD), can be expressed in vitro as a soluble protein of
240 amino acids that retains cholesterol-binding activity (Infante
et al., 2008b).
An important difference between NPC2 and NPC1(NTD) lies in
the kinetics of sterol binding. When incubated at 4C, NPC2
binds and releases cholesterol rapidly (half-time <2 min) (Infante
et al., 2008c). This rapid binding allows NPC2 to transfer choles-
terol from one liposome to another (Babalola et al., 2007).
In contrast, at 4C NPC1(NTD) binds cholesterol very slowly
(half-time >2 hr) (Infante et al., 2008c). Cholesterol binding to
NPC1(NTD) is accelerated by >15-fold when the sterol is first
bound to NPC2 and then transferred to NPC1(NTD). Unlike
NPC2, NPC1(NTD) cannot rapidly transfer its bound cholesterol
to liposomes (Infante et al., 2008c). However, NPC1(NTD) can
accomplish this delivery when NPC2 is present (Infante et al.,
2008c). These data led us to advance a model in which NPC2
can mediate bidirectional transfer of cholesterol to or from
NPC1(NTD). In cells, we envision that NPC2 accepts cholesterol
in the lysosomal lumen and transports it to membrane-bound
NPC1, thus accounting for the requirement for both proteins
for lysosomal cholesterol export (Infante et al., 2008c; Kwon
et al., 2009).
The crystallographic structure of NPC1(NTD) with bound sterol
gave a clue as to the possible requirement for NPC2. In NPC1
(NTD), entrance into the cholesterol-binding pocket is ob-
structed by a helices that must move aside to permit entry or
exit, thus explaining the slow binding of cholesterol when deliv-
ered in solution (Kwon et al., 2009). We envision that NPC2 binds
to NPC1(NTD), displacing the helices and allowing direct transfer
of cholesterol into the binding pocket of NPC1(NTD). This direct
transfer avoids the necessity for insoluble cholesterol to transit
the water phase. In the current study, we test this transfer.
Figure 1. Alanine Scan Mutagenesis of
NPC2
(A and C) [3H]Cholesterol binding to NPC2 in
culture medium from transfected cells. Each reac-
tion, in final volume of 160 ml, contained 110 ml
buffer B, 50 ml concentrated medium as described
in the Experimental Procedures, 1.9 mg BSA,
0.004% NP-40, and [3H]cholesterol (A, indicated
concentration at 222 3 103 dpm/pmol; C,
200 nM at 132 3 103 dpm/pmol). After 2 hr at
4C, the amount of bound [3H]cholesterol was
measured as described in the Experimental
Procedures except reactions were not diluted
before loading onto Ni-NTA columns. (A) Each
value represents total binding after subtraction of
blank value (<0.03 pmol/tube). (C) Each bar
(average of duplicate assays; mean variation ±
SEM for all duplicate values, 9.6% ± 1.2%) repre-
sents binding relative toWTNPC2 studied in same
experiment. All binding data were adjusted for
variations (typically < 2-fold) in the amount of
secreted NPC2 protein as determined by densito-
metric scanning of immunoblots of the assayed
protein in the eluate. The data in the graph were
obtained in five separate experiments. The
‘‘100% of control’’ values (WT NPC2) averaged
1.5 pmol/tube (average value for mock-
transfected cells in same five experiments
was <0.1 pmol/tube). The entire alanine scan
was repeated in an independent experiment with
similar results. Blue bars denote residues that
when mutated to alanine decrease binding
by >85%. (B and D) [3H]Cholesterol transfer from
NPC1(NTD) to liposomes in presence of NPC2
contained in culture medium from transfected
cells. Each reaction, in a final volume of 200 ml,
contained 130 ml buffer A (pH 5.5), 40 pmol of
WT NPC1(NTD)-LVPRGS-His8-FLAG complexed to [3H]cholesterol (132 3 103 dpm/pmol), 20 mg PC liposomes, and concentrated medium (B, 0–10 ml; D,
30 ml). After 10 min at 4C, [3H]cholesterol transferred to liposomes was measured as described in the Experimental Procedures (assay C). (B) Each value repre-
sents percentage of [3H]cholesterol transferred after subtraction of percentage in absence of medium (11% transfer). The 100% value for transfer was 0.14 pmol/
tube. (D) Each bar (average of duplicate assays; mean variation ± SEM for all duplicate values, 8.8% ± 1.1%) denotes percentage of [3H]cholesterol transferred in
presence of NPC2 after subtraction of percentage in absence of NPC2. The data in the graph were obtained in five separate experiments. The ‘‘100% of control’’
values (WT NPC2) averaged 38% transfer of total input (average value for mock-transfected cells in the same five experiments was 1.8%). The entire alanine scan
was repeated in an independent experiment with similar results. Red bars denote residues that when mutated to alanine decrease NPC2-mediated [3H]choles-
terol transfer by >60%. (E) Ribbon diagram of bovine NPC2 (Xu et al., 2007), showing positions of residues crucial for cholesterol binding (blue) and transfer (red).
Residue P100 is only one of 14 residues important for binding [3H]cholesterol that does not map to sterol-binding pocket. Residue 81 (Ile bovine sequence; Val in
human) was identified in above alanine scan as essential for [3H]cholesterol transfer, but not binding. Residue P120 was previously identified as essential for both
binding and transfer (Infante et al., 2008c). Bound cholesterol sulfate is shown in green. (C–E) Amino acid residues are numbered starting at the initiator methi-
onine (residue number 1). The first amino acid after signal peptide cleavage is residue number 20.
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Hydrophobic Handoff of Cholesterol in Lysosomeshypothesis by producing mutant forms of NPC2 and NPC1(NTD)
that can bind cholesterol but cannot engage in transfer from one
protein to the other. These transfer mutants map to discrete
regions on the surface of the two proteins that may be sites
where the two proteins interact.
RESULTS
Alanine Scan Mutagenesis to Identify Residues of NPC2
Required for Cholesterol Binding and Transfer
To establish an assay to screen for residues in NPC2 that are
essential for cholesterol binding or transfer to NPC1(NTD), we
transfected CHO-K1 cells with plasmids encoding histidine-
tagged WT or mutant NPC2. Like other lysosomal proteins
(Kornfeld, 1987), a portion of NPC2 was secreted into the cultureCelmedium. To measure binding ability, aliquots of media were
incubated with [3H]cholesterol, and the NPC2-bound sterol
was isolated by nickel chromatography. When cells expressed
WT NPC2, the His-tagged NPC2 in the medium bound [3H]
cholesterol, whereas medium from mock-transfected cells
showed no binding (Figure 1A). To measure cholesterol transfer,
we used a previously described liposome transfer assay (Infante
et al., 2008c). First, purified NPC1(NTD) was incubated with
[3H]cholesterol and the bound sterol was separated from free
[3H]cholesterol by gel filtration chromatography as described in
the Experimental Procedures. The isolated [3H]cholester-
ol:NPC1(NTD) complex was then incubated with phosphatidyl-
choline (PC) liposomes, and the amount of [3H]cholesterol
transferred to liposomes was measured. In the presence of
culture medium from mock-transfected cells, NPC1(NTD) failedl Metabolism 12, 166–173, August 4, 2010 ª2010 Elsevier Inc. 167
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Transfer was stimulated markedly in the presence of culture
medium containing WT NPC2.
We next prepared 57 plasmids encoding mutant forms of
NPC2 in which one, two, or three sequential amino acids were
changed to alanine. (Amino acid residues are numbered starting
at the initiator methionine, which is designated number 1; the first
residue after signal peptide cleavage is number 20.) Our mutant
panel included all residues in NPC2 that are exposed to the
surface (Xu et al., 2007). We did not mutate any of the six cyste-
ines or the single residue that was already alanine. We also did
not mutate P120. When P120 is changed to serine, as in certain
patients with NPC2 disease (Verot et al., 2007), binding of [3H]
cholesterol is abolished (Infante et al., 2008c). The mutant plas-
mids were introduced into CHO-K1 cells by transfection. We
assayed aliquots of culture media that contained equivalent
amounts of NPC2 as determined by immunoblotting. Thirteen
of the 57 NPC2 mutant proteins showed binding that was less
than 15% of the WT value determined in the same experiment
(Figure 1C, blue). As shown in blue (with the exception of
P100, which is remote), these mutations replaced residues that
surround the sterol-binding pocket as delineated in the crystal
structure of Xu et al. (Xu et al., 2007) (Figure 1E). Moreover, the
results of our mutant screen are consistent with three binding
mutants identified by Ko et al. (2003), who used a different
screening assay based on complementation by endocytosis of
heterologously expressed mutant NPC2 proteins. Their binding
mutants (F66, V96, and Y100) correspond in our numbering
scheme to residues F85, V115, and Y119. (The first 19 amino
acids comprising the signal peptide are included in our
numbering.) In our screen, F85A and Y119A gave binding values
of 3% and 8% of WT. Amino acid V115 was not included in our
alanine scan, but the two adjacent residues, P114 and K116,
when mutated to alanine, gave binding values of 15% and 5%
as compared to WT (Figure 1C).
We used the liposome transfer assay to analyze transfer
activity in culture media from all of the alanine scan mutants
whose [3H]cholesterol-binding activity exceeded 50% of WT
(Figure 1D). Three of these mutants exhibited transfer activity
that was less than 40% of WT (Figure 1D, red). All three of these
closely spaced residues map to a surface patch on NPC2 that is
adjacent to the opening of the cholesterol-binding pocket
(Figure 1E, red). When the alanine scan was repeated in its
entirety in an independent experiment, the same three mutants
were identified and none of the other tested mutants showed
defective transfer activity.
Biochemical Characterization of NPC2 Cholesterol
Transfer Mutant
To further explore the transfer defect detected in the mutant
screen, we studied additional amino acid substitutions at the
valine-81 position. We used nickel affinity and gel filtration chro-
matography to purify His-tagged WT and mutant NPC2 proteins
from culture media. Increasing amounts of purified WT NPC2
stimulated transfer of [3H]cholesterol from NPC1(NTD) to
liposomes, whereas the V81A mutant was less effective
(Figure 2A). When valine-81 was changed to aspartic acid
(V81D), the transfer defect was even greater (Figure 2A).
Figure 2B shows the results of a 2 hr equilibrium binding assay168 Cell Metabolism 12, 166–173, August 4, 2010 ª2010 Elsevier Incat 4C, indicating that the V81A and V81D mutants both bound
cholesterol with affinities indistinguishable from WT. The calcu-
lated Kd values were 81, 80, and 72 nM for WT, V81A, and
V81D, respectively. The V81D mutant and the WT protein
showed identical rates of association with [3H]cholesterol at
4C (Figure 2C). To measure dissociation rates, we first isolated
a [3H]cholesterol:NPC2 complex by gel filtration, then diluted the
complex, and then measured the rate of dissociation of bound
[3H]cholesterol. Both proteins exhibited identical dissociation
rates at 4C, and both were markedly accelerated at 37C
(Figure 2D). We used the isolated [3H]cholesterol:NPC2
complexes as donors to measure the direct transfer of [3H]
cholesterol to NPC1(NTD) (Figure 2E). The V81A mutant was
partially defective in this transfer, and the V81D mutant was
severely defective.
NPC2 Cholesterol Binding and Transfer Mutants Fail
to Restore Function to NPC2-Deficient Cells
To confirm that the transfer mutants are defective in living cells,
we measured the ability of WT and mutant NPC2 proteins to
restore egress of LDL-derived cholesterol in fibroblasts from
a patient with two defective NPC2 alleles. We incubated the
cells with [14C]oleate and measured the rate of its incorporation
into cholesteryl [14C]oleate, a reaction that requires movement
of LDL-derived cholesterol from lysosomes to ER (Goldstein
et al., 1983). In WT cells, LDL caused a marked increase in cho-
lesteryl [14C]oleate formation (Figure 3A), whereas the mutant
NPC2 cells showed no response. Both cells responded to 25-
hydroxycholesterol, which enhances cholesteryl [14C]oleate
synthesis in a fashion that does not require the lysosome. To
correct the NPC2 phenotype in the mutant cells, we took
advantage of the fact that NPC2 is a lysosomal protein that
contains mannose-6-phosphate residues that mediate its
cellular uptake and delivery to lysosomes (Naureckiene et al.,
2000; Chikh et al., 2004). In the presence of LDL, addition of
purified WT NPC2 protein to the culture medium led to
a marked increase in cholesteryl [14C]oleate synthesis in the
mutant NPC2 cells (Figure 3B). There was little stimulation
when we added the previously described cholesterol-binding
mutant of NPC2 (P120S) (Infante et al., 2008c). We also found
little stimulation with the cholesterol transfer mutant (V81D).
None of these proteins influenced cholesteryl [14C]oleate
synthesis in control fibroblasts (Figure 3C). We repeated these
experiments with NPC2 proteins that contained a FLAG epitope
tag and observed identical results (see Figures S1A and S1B,
available online). Immunoblotting of cell extracts with anti-
NPC2 confirmed that both control and mutant fibroblasts
took up all three proteins (Figure S1C).
Biochemical Characterization of NPC1(NTD)
Cholesterol Transfer Mutant
Previously, we described a mutation in NPC1(NTD) that did not
alter cholesterol binding but partially reduced the ability of the
NPC1(NTD) to transfer cholesterol to or from NPC2 (Kwon
et al., 2009). This mutation converted two adjacent leucines to
alanine (L175A/L176A). To increase this transfer defect, we
changed the two leucines to glutamines (L175Q/L176Q). When
incubated with [3H]cholesterol in solution for 24 hr at 4C, this
mutant protein bound [3H]cholesterol indistinguishably from.
Figure 2. Biochemical Analysis of NPC2
Transfer-Defective Mutants
(A) [3H]Cholesterol transfer from NPC1(NTD) to
liposomes as a function of NPC2. Each reaction,
in a final volume of 200 ml buffer A (pH 5.5), con-
tained 50 pmol of WT NPC1(NTD)-LVPRGS-
His8-FLAG complexed to [3H]cholesterol (222 3
103 dpm/pmol), 20 mg PC liposomes, and the indi-
cated concentration ofWT ormutant NPC2-His10.
After 10 min at 4C, [3H]cholesterol transferred to
liposomes was measured as described in the
Experimental Procedures (assay C). Each value
represents percentage of [3H]cholesterol trans-
ferred. A blank value in the absence of NPC2
(7% transfer) was subtracted. The 100% value
for transfer was 1.9 pmol/tube.
(B) [3H]Cholesterol binding. Each reaction, in a final
volume of 80 ml buffer A (pH 5.5) with 0.004%
NP-40, contained 8 pmol of purified WT or mutant
NPC2-His10, 1 mg BSA, and the indicated concen-
tration of [3H]cholesterol (222 3 103 dpm/pmol).
After 2 hr at 4C, bound [3H]cholesterol was
measured. Each value represents total binding
after subtraction of blank value (<0.1 pmol/tube).
(C) Time course of association of [3H]cholesterol to
NPC2. Each reaction, in a final volume of 80 ml of
buffer A (pH 5.5) with 0.004% NP-40, contained 8 pmol of WT or mutant NPC2-His10 and 200 nM [3H]cholesterol (132 3 103 dpm/pmol). After incubation for
indicated time at 4C, bound [3H]cholesterol was determined. Each value represents total binding after subtraction of a blank value (<0.03 pmol/tube).
(D) Dissociation of previously bound [3H]cholesterol fromNPC2 at different temperatures. Dissociation of [3H]cholesterol from [3H]cholesterol:NPC2-His10 (WT or
mutant) was measured as described in the Experimental Procedures. Each value represents the percentage of [3H]cholesterol remaining bound to WT or mutant
NPC2 relative to zero-time value. The ‘‘100% initial binding’’ values at zero time for NPC2 was 0.48 (WT) and 0.26 (mutant) pmol/tube.
(E) [3H]Cholesterol transfer from NPC2 to NPC1(NTD). Each reaction, in a final volume of 200 ml buffer A (pH 5.5), contained 40 pmol of WT or mutant NPC2-
His10 complexed to [3H]cholesterol (222 3 103 dpm/pmol) and the indicated concentration of WT NPC1(NTD)-LVPRGS-His8-FLAG. After 10 min at 4C, [3H]
cholesterol transferred was measured as described in the Experimental Procedures (assay B). Each value represents percentage of [3H]cholesterol transferred
to NPC1(NTD). Blank values in the absence of NPC1(NTD) (0.1%–0.5% transfer) were subtracted. The 100% values for transfer fromWT, V81A, and V81D NPC2
were 0.24, 0.78, and 0.29 pmol/tube, respectively.
(A–E) Each value is the average of duplicate assays.
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cholesterol for 10 min, WT NPC1(NTD) accepted the [3H]choles-
terol, whereas the L175Q/L176Q mutant was nearly devoid of
acceptor activity (Figure 4B). Thus, the L175Q/L176Q mutant
of NPC1(NTD) is analogous to the V81D mutant of NPC2. Both
mutant proteins can bind cholesterol but cannot transfer it to
the other protein.(A–C) After 5 hr at 37C, each cell monolayer was pulse-labeled for 1 hr with 0.2 m
oleate and [14C]triglycerides were determined. Each value is the average of dup
treated with 60 mg/ml LDL and 3 mg/ml of WT, V81D, or P120S NPC2-His10 prot
CelNPC1 Cholesterol Transfer Mutant Fails to Restore
Function to NPC1-Deficient Cells
To confirm that the L175Q/L176Q mutation disrupted the
function of NPC1 in living cells, we introduced this mutation
into a plasmid encoding full-length NPC1. Plasmids encoding
WT or L175Q/L176Q mutant NPC1 were transfected into CHO
4-4-19 cells, which are deficient in NPC1 (Dahl et al., 1992). ToFigure 3. Ability of WT NPC2, but Not
Mutant NPC2, to Rescue LDL-Stimulated
Cholesteryl Ester Formation in NPC2-Defi-
cient Human Fibroblasts
(A) Control and NPC2-deficient cells were set up
for experiments as described in the Experimental
Procedures. On day 7, cells were switched to
medium B containing 5% lipoprotein-deficient
serum, 50 mM compactin, and 50 mM sodium me-
valonate in the absence or presence of 10 mg/ml
25-hydroxycholesterol (25-HC) or 60 mg protein/
ml LDL as indicated.
(B and C) On day 7, cells were switched to above
medium supplemented with 60 mg protein/ml LDL
and indicated concentration of purified WT or
mutant NPC2-His10.
M sodium [14C]oleate (3480 dpm/nmol), and cellular content of cholesteryl [14C]
licate incubations. Content of [14C]triglycerides in NPC2-deficient fibroblasts
eins was 3.1, 3.0, and 4.0 nmol/hr per mg protein, respectively.
l Metabolism 12, 166–173, August 4, 2010 ª2010 Elsevier Inc. 169
Figure 4. Biochemical Analysis of NPC1(NTD) Transfer-Defective
Mutant
(A) [3H]Cholesterol binding. Each reaction, in a final volume of 80 ml buffer A (pH
5.5) with 0.004% NP-40, contained 4 pmol purified WT or mutant NPC1(NTD)-
LVPRGS-His8-FLAG, 1 mg BSA, and indicated concentration of [3H]choles-
terol (132 3 103 dpm/pmol). After 24 hr at 4C, bound [3H]cholesterol was
measured. Each value represents total binding after subtraction of a blank
value (<0.06 pmol/tube).
(B) [3H]Cholesterol transfer from NPC2 to NPC1(NTD). Each reaction, in a final
volume of 100 ml buffer A (pH 5.5), contained 24 pmol of NPC2-FLAG com-
plexed to [3H]cholesterol (1323 103 dpm/pmol) and indicated concentration of
WT or mutant NPC1(NTD)-LVPRGS-His8-FLAG. After 10 min at 4C, [3H]
cholesterol transferred wasmeasured as described in the Experimental Proce-
dures (assay A). Each value represents percentage of [3H]cholesterol trans-
ferred to NPC1(NTD). A blank value in the absence of NPC1(NTD) (0.3% trans-
fer) was not subtracted. The 100% value for transfer from NPC2 was 0.85
pmol/tube.
(A and B) Each value is the average of duplicate assays.
Figure 5. Failure of Mutant L175Q/L176Q Version of Full-Length
NPC1 to Rescue Cholesteryl Ester Formation in NPC1-Defective
Hamster Cells
(A) Cholesterol esterification in response to b-VLDL. NPC1-deficient CHO
4-4-19 cells were transfected on day 1 with 2 mg pcDNA3.1 (mock), WT
pCMV-NPC1-His8-FLAG, or its mutant version (L175Q/L176Q) as described
in the Experimental Procedures. Five hours after transfection, the medium
was switched to medium A containing 5% newborn calf lipoprotein-deficient
serum. On day 2, the medium was switched to the same medium containing
5 mM compactin and 50 mM sodium mevalonate. After 16 hr, fresh medium
containing 50 mM compactin, 50 mM sodium mevalonate, and the indicated
concentration of b-VLDL was added. After 5 hr at 37C, each monolayer
was pulse-labeled for 1 hr with 0.2 mM sodium [14C]oleate (7433 dpm/nmol).
The cells were then harvested for measurement of their content of cholesteryl
[14C]oleate and [14C]triglycerides as described in the Experimental Proce-
dures. Each value is the average of duplicate incubations. The content of
[14C]triglycerides for mock, WT, and mutant NPC1 transfected cells incubated
with 10 mg/ml b-VLDL was 201, 222, and 129 nmol/hr per mg protein, respec-
tively. Inset shows an immunoblot of whole-cell extracts from the various
transfected cells probed with anti-FLAG antibody as described in the Experi-
mental Procedures.
(B) Deglycosidase treatment. NPC1-deficient CHO cells were transfected with
the indicated plasmid as in (A). Five hours after transfection, the medium was
switched to medium A with 5% FCS. Two days later, cells were harvested,
and their solubilized membranes were treated with glycosidase EndoH or
PNGaseF and then subjected to immunoblot analysis with anti-FLAG antibody
as described in the Experimental Procedures.
(A and B) Filters were exposed to film for 10 s at room temperature.
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[14C]oleate after administration of b-VLDL, a cholesterol-rich
lipoprotein that binds to hamster LDL receptors more avidly
than does human LDL. In mock-transfected CHO 4-4-19 cells,
b-VLDL did not stimulate cholesteryl ester synthesis (Figure 5A).
Expression of WT NPC1 permitted a marked stimulation,
whereas the L175Q/L176Q mutant was much less effective.
The transfected cells expressed similar amounts of WT and
L175Q/L176Q NPC1 as determined by immunoblotting (Fig-
ure 5A, inset). In both proteins, the N-linked carbohydrate chains
were partially resistant to treatment with endoglycosidase H,
indicating that the proteins had folded properly and reached
the Golgi apparatus. Treatment with PNGaseF lowered the
apparent molecular mass of both proteins as a result of removal
of all N-linked carbohydrates (Figure 5B).DISCUSSION
In the current studies, we used alanine-scanning mutagenesis to
identify residues in NPC2 that are important for cholesterol
binding and for cholesterol transfer to or from NPC1(NTD).
When the crucial residues aremapped to the published structure
of NPC2 (Xu et al., 2007), they reveal that the binding-defective
mutations cluster around the sterol-binding pocket. Three of
the mutant proteins bound cholesterol normally but failed to
catalyze the transfer of cholesterol from NPC1(NTD) to PC lipo-
somes. These three sites were all on the surface of the protein
in a patch that is adjacent to the opening of the sterol-binding
pocket.170 Cell Metabolism 12, 166–173, August 4, 2010 ª2010 Elsevier IncWe previously performed a similar alanine-scanning mutagen-
esis study of NPC1(NTD) (Kwon et al., 2009). In that study, we
identified 11 amino acids whose replacement disrupted transfer
without disrupting cholesterol binding. These residues clustered
in a surface patch of NPC1(NTD) that surrounds the helices that
must be moved aside in order for cholesterol to enter the binding
pocket. The finding that transfer mutants in both proteins cluster
in surface patches raises the possibility that these two patches
must interact in order for NPC2 to open the binding pocket of
NPC1(NTD) so that cholesterol can move between the two
proteins. Figure 6 shows a model illustrating one way in which
these two proteins could interact. The hypothesis of direct inter-
action between NPC2 and NPC1(NTD) is by no means proven.
So far we have been unable to demonstrate a stable physical
complex between these two proteins with or without cholesterol
in the binding pockets.
The model for direct cholesterol transfer between NPC2 and
NPC1(NTD) is formally analogous to the proposed model for
substrate channeling between two sequential enzymes in
a biochemical pathway (Anderson, 1999). A well-studied
example of substrate channeling is the transfer of b-aspartyl.
Figure 6. Conceptual Model Illustrating One Possible Mechanism
of Interaction between NPC2 and NPC1(NTD)
This model is based on the published structures of sterol-bound NPC2
(Xu et al., 2007) and sterol-bound NPC1(NTD) in the putative open conforma-
tion (Kwon et al., 2009). A stable complex between NPC2 and NPC1(NTD) has
not been demonstrated experimentally, and the interaction models in (A) and
(B) are hypothetical.
(A) Surface representation showing residues in NPC2 (purple) and NPC1(NTD)
(green) that are crucial for transfer of cholesterol (red) between NPC2 and
NPC1(NTD). The cholesterol molecule is shown after its transfer to NPC1
(NTD). The two proteins are positioned so that the openings in their respective
sterol-binding pockets are juxtaposed and the planes of the cholesterol-
binding pockets in NPC2 and NPC1(NTD) are aligned.
(B) Cutaway view of the NPC2:NPC1(NTD) complex shown in (A), revealing
alignment of the cholesterol-binding pockets and juxtaposition of the surface
patches on both proteins postulated to be crucial for protein-protein
interaction.
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I and aspartate semialdehyde dehydrogenase (James and Viola,
2002). So far, the evidence for such channeling is kinetic, much
like the current evidence for cholesterol transfer in the NPC2/
NPC1(NTD) system. To our knowledge, direct complexes
between two different enzymes in substrate channeling have
not been demonstrated. On the other hand, in the case of
tryptophan synthase in which two sequential enzymes are linked
together in a a2b2 tetrameric complex, crystallographic studies
document intersections between the two active sites (Anderson,
1999).
In the case of channeling systems not involving stable hetero-
dimeric complexes, it is likely that the interactions are transient,
and additional methods, such as chemical crosslinking, may be
necessary to freeze the contacts so as to permit a direct demon-
stration of relevant interactions. Initial efforts to use nonspecific
crosslinkers to detect interaction between NPC2 and NPC1
(NTD) have so far been unsuccessful. We have also been unsuc-
cessful in using several detection methods such as gel filtration,CelBiacore, and AlphaScreen. Transfer-defective mutants like
NPC2(V81D) provide negative controls that allow us to study
only the physiologically relevant interactions.
The transfer of cholesterol from NPC2 to NPC1(NTD) has
a special functional relevance in light of the near-absolute insol-
ubility of cholesterol in water. Our model envisions that NPC2
binds cholesterol the instant that it is released from LDL, either
as the free sterol or after cleavage of cholesteryl esters by lyso-
somal acid lipase. This binding would prevent cholesterol from
crystallizing in the lysosomal lumen. According to the model,
NPC2 can transfer its bound cholesterol to NPC1(NTD) directly,
thus avoiding the necessity for the insoluble cholesterol to transit
the water phase. We have named this process a ‘‘hydrophobic
handoff.’’ Additional studies will be needed to test and validate
this model. The transfer mutants described in this paper should
facilitate this validation.
EXPERIMENTAL PROCEDURES
Materials
Weobtained [1,2,6,7-3H]cholesterol (60 or 100Ci/mmol) fromAmerican Radio-
labeled Chemicals; anti-FLAG M2-Agarose affinity beads, FLAG peptide, and
anti-FLAG M2 antibody from Sigma; Nonidet P-40 from Roche Applied
Sciences; Ni-NTA-agarose beads from QIAGEN; egg yolk L-a-phosphatidyl-
choline (PC) and Texas red dye from Avanti Polar Lipids; Cellgro ITS (insulin,
transferrin, selenium) fromMediatech, Inc.; glycosidase Endo H and PNGaseF
fromNewEngland Biolabs; Superdex 200 10/300GL columns fromGEHealth-
care Biosciences; andBovine SerumAlbumin Standard (2mg/ml) fromThermo
Scientific. Reagents and lipoproteins for assays of cholesterol esterification
were as previously described (Goldstein et al., 1983; Infante et al., 2008a).
Buffers and Media
Buffer A contained 50mMMES (pH 5.5 or 6.5) and 150mMNaCl. Buffer B con-
tained 50 mM Tris-chloride (pH 7.4) and 150 mM NaCl. Buffer C contained
10 mM HEPES (pH 7.6), 1.5 mM MgCl2, 10 mM KCl, 5 mM sodium EDTA,
5 mM sodium EGTA, and 250 mM sucrose. Buffer D contained 10 mM
Tris-chloride (pH 6.8), 100 mM NaCl, and 0.5% (w/v) SDS. Buffer E contained
62.5 mM Tris-chloride (pH 6.8), 15% SDS, 8 M urea, 10% (v/v) glycerol, and
100 mM DTT. Medium A contained a 1:1 mixture of Ham’s F12 medium and
DMEM, 100 units/ml penicillin, and 100 mg/ml streptomycin sulfate. Medium
B contained DMEM, 100 units/ml penicillin, and 100 mg/ml streptomycin
sulfate.
Plasmid Construction
Four previously described plasmids were used in these studies. All four are
under the control of the CMV promoter. pCMV-NPC1-His8-FLAG encodes
WT human NPC1 followed sequentially by eight histidines and a FLAG tag
(Infante et al., 2008a). pCMV-NPC1(1-264)-LVPRGS-His8-FLAG encodes the
NTD of WT human NPC1 (amino acids 1–264) followed sequentially by
a thrombin cleavage site (LVPRGS), eight histidines, and a FLAG tag (Infante
et al., 2008c). pCMV-NPC2-His10 encodes WT human NPC2 (amino acids
1–151) followed sequentially by ten histidines (Infante et al., 2008b). pCMV-
NPC2-FLAG encodesWT human NPC2 (amino acids 1–151) followed sequen-
tially by a FLAG tag (Infante et al., 2008c).
Mutations in the above plasmid constructs were generated by site-directed
mutagenesis (Stratagene QuikChange Site-Directed Mutagenesis Kit). The
coding regions of all plasmids were sequenced to ensure integrity of each
construct.
Purification of Epitope-Tagged NPC1(NTD) and NPC2 from Medium
of Transfected CHO Cells
NPC proteins were purified from the media of stably or transiently transfected
CHO-K1 cells (Infante et al., 2008c). NPC proteins containing a histidine tag
(with or without a FLAG tag) were purified by Ni-NTA-agarose and gel filtration
chromatography; NPC proteins with only a FLAG tag were purified byl Metabolism 12, 166–173, August 4, 2010 ª2010 Elsevier Inc. 171
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stably transfected cells were WT versions of pCMV-NPC1(1–264)-LVPRGS-
His8-FLAG and pCMV-NPC2-FLAG. Plasmids used for transient transfections
were mutant versions of pCMV-NPC1(1–264)-LVPRGS-His8-FLAG, mutant
versions of pCMV-NPC2-FLAG, and WT and mutant versions of pCMV-
NPC2-His10. The concentration of purified protein was determined with the
BCA assay (Smith et al., 1985).
[3H]Cholesterol-Binding Assay
This assay was previously described (Infante et al., 2008b). Incubation condi-
tions are detailed in the figure legends. After incubation for the indicated time
at 4C, each reaction was diluted 5-fold with ice-cold buffer B containing
0.004% (v/v) NP-40, loaded onto a 2 ml Bio-Spin column (Bio-Rad) packed
with 0.3 ml of Ni-NTA-agarose beads that had been preequilibrated with buffer
B containing 0.004% NP-40. The beads were washed with either 5 ml buffer B
with 1% NP-40 for NPC1(NTD) or 6 ml buffer B with 0.004% NP-40 for NPC2.
Protein-bound [3H]cholesterol was eluted with 1 ml buffer B containing 250
mM imidazole and 1% or 0.5%NP-40 for NPC1(NTD) and NPC2, respectively,
and quantified by scintillation counting.
Preparation of Complexes of [3H]Cholesterol:NPC1(NTD) and [3H]
Cholesterol:NPC2
To prepare material for the [3H]cholesterol dissociation assays, we incubated
500 nM [3H]cholesterol (1323 103 dpm/pmol) and 30 mg NPC2-His10 in a final
volume of 300 ml of buffer A (pH 5.5). To preparematerial for the [3H]cholesterol
transfer assays, we incubated 500 nM [3H]cholesterol (132 3 103 or 222 3
103 dpm/pmol) in a final volume of 500 ml buffer A (pH 5.5) with one of the
following proteins: 20 mg NPC2-His10, 30 mg NPC2-FLAG, or 100 mg NPC1
(NTD)-LVPRGS-His8-FLAG. After incubation for 10 min at 37C and then
30 min at 4C, the solution was passed at 4C through a 24 ml Superdex 200
column that had been preequilibrated with buffer A (pH 5.5). Protein-bound
[3H]cholesterol emerged between 15.5 and 18.5 ml for NPC2 and between
13.5 and 16.5 ml for NPC1(NTD). The respective pooled fractions were used
for the [3H]cholesterol dissociation and transfer assays described below.
[3H]Cholesterol Dissociation Assay
[3H]Cholesterol:NPC2-His10 was isolated at 4C (3 ml), diluted 9-fold with ice-
cold buffer A (pH 6.5) containing 0.004% NP-40 and 11.25 mM unlabeled
cholesterol, and then incubated at 4C or 37C. At the indicated time, a 1 ml
aliquot of the pooled 27 ml sample was transferred to a tube containing
600 ml of Ni-NTA-agarose beads. After incubation for 3 min at 4C, the beads
were centrifuged at 800 g for 1min at room temperature, after which the super-
natant was assayed for radioactivity.
[3H]Cholesterol Transfer Assays
Three types of transfer assays were performed. Incubation conditions for the
assays are detailed in figure legends. Assay A involves the transfer of [3H]
cholesterol from donor NPC2-FLAG to acceptor NPC1(NTD)-LVPRGS-His8-
FLAG. After incubation for 10 min at 4C, each 100 ml reaction mixture was
diluted with 500 ml of ice-cold buffer B and loaded onto a 2 ml column packed
with 0.3 ml Ni-NTA-agarose beads that had been preequilibrated with buffer B.
Each column was washed with 3 ml buffer B, after which NPC1(NTD)-
LVPRGS-His8-FLAG was eluted with 1 ml buffer B containing 250 mM
imidazole. The amount of [3H]cholesterol transferred to NPC1(NTD)-
LVPRGS-His8-FLAG was quantified by scintillation counting of the eluate.
Assay B involves the transfer of [3H]cholesterol from donor NPC2-His10 to
acceptor NPC1(NTD)-LVPRGS-His8-FLAG. After incubation for 10 min at
4C, each 200 ml reaction mixture was diluted with 500 ml of ice-cold buffer
B and loaded onto a 2ml column packed with 0.2 ml of anti-FLAGM2-agarose
beads that had been preequilibrated with buffer B. Each column was washed
with 3 ml buffer B, after which NPC1(NTD)-LVPRGS-His8-FLAG was eluted
with 1 ml buffer B containing 0.1 mg/ml FLAG peptide. The amount of [3H]
cholesterol transferred to NPC1(NTD)-LVPRGS-His8-FLAG was quantified
by scintillation counting of the eluate.
Assay C involves the transfer of [3H]cholesterol from donor NPC1(NTD) to
acceptor PC liposomes. PC liposomes labeled with Texas red dye were
prepared as described (Infante et al., 2008c). After incubation for 10 min at
4C, each reaction was diluted with 750 ml ice-cold buffer B, loaded onto172 Cell Metabolism 12, 166–173, August 4, 2010 ª2010 Elsevier Inca 2 ml column packed with 0.3 ml Ni-NTA-agarose beads that had been pre-
equilibrated with buffer B, and then washed with 1 ml buffer B. The amount of
[3H]cholesterol transferred to liposomes was quantified by scintillation count-
ing of the flowthrough plus 1 ml buffer B wash.
Alanine Scan Mutagenesis of NPC2
We prepared 57 plasmids encoding mutant forms of NPC2 in which one, two,
or three sequential amino acids were changed to alanine by site-directed
mutagenesis (Stratagene QuikChange Site-Directed Mutagenesis Kit). (Amino
acid residues are numbered starting at the initiator methionine, which is desig-
nated number 1.) To evaluate the NPC2 proteins encoded by these plasmids,
the plasmids were transfected into CHO-K1 cells, after which assays for [3H]
cholesterol binding and transfer were performed with the secreted proteins.
CHO-K1 cells were grown inmonolayer at 37C in 8%–9%CO2. On day 0, cells
were plated at a density of 63 106 cells per 100mm dish in medium A contain-
ing 5% (v/v) FCS. On day 2, dishes were transfected with 5 mg pcDNA3.1 or
pCMV-NPC2-His10 (WT or mutant versions) as described (Rawson et al.,
1999). On day 3, each dish was washed once with 10 ml Dulbecco’s PBS
and then switched to 7 ml medium A containing 1% (v/v) ITS. On day 6, the
media from five dishes (35 ml) was collected and concentrated to 0.5 ml using
a 10 kDa Amicon Ultra-15 Centrifugal Filter Unit (Millipore). The amount of
secreted NPC2 in the concentrated media was estimated by densitometric
scanning of immunoblots with anti-NPC2 antibody. Aliquots of the concen-
trated media containing either WT or mutant version of NPC2-His10 were
used for the [3H]cholesterol-binding and transfer assays.
Cholesterol Esterification Assay in Intact Cells
Cholesterol esterification assays were done with human fibroblasts as
described (Goldstein et al., 1983). On day 0, control and NPC2-deficient fibro-
blasts (GM 18455; compound heterozygote with mutant alleles E20X and
C47F; obtained from Coriell Institute for Medical Research) were set up in
medium B containing 10% FCS at 25 3 103 and 100 3 103 cells/60 mm
dish, respectively, and grown in monolayer at 37C in 5% CO2. On day 3, cells
were refed with the samemedium. On day 5, cells were washed once with PBS
and switched to medium B containing 10% human lipoprotein-deficient serum
and 1% ITS. On day 7, cells were used for experiments. After incubation for
5 hr at 37C with various additions as described in figure legends, each cell
monolayer was pulse-labeled for 1 hr with 0.2 mM sodium [14C]oleate. The
rate of incorporation of [14C]oleate into cholesteryl [14C]oleate and [14C]triglyc-
erides by intact cell monolayers was measured as described (Goldstein et al.,
1983; Kwon et al., 2009).
Cholesterol esterification assays were also done in mutant CHO 4-4-19 cells
defective in NPC1 function (Dahl et al., 1992). Cells were set up for experiments
at 400 3 103 cells/60 mm dish in medium A with 5% FCS, transfected with
2–2.5 mg of the indicated plasmid on day 1 as described (Infante et al.,
2008b), and incubated with various additions as described in figure legends,
after which the incorporation of [14C]oleate into cellular cholesteryl [14C]oleate
and [14C]triglycerides was determined.
Glycosidase Treatment
Forty-eight hours after transfection, NPC1-deficient CHO 4-4-19 cells were
harvested, washed with PBS, and lysed in 200 ml buffer C containing 5 mg/ml
pepstatin, 10 mg/ml leupeptin, and 1.9 mg/ml aprotinin by passing through
a 22 gauge needle 30 times. The lysate was centrifuged at 2200 rpm for
5 min at 4C. The supernatant was then centrifuged at 100,000 g for 30 min
at 4C. The pellet was then resuspended in 100 ml buffer D and shaken for
30 min at room temperature. Reactions, in a final volume of 100 ml buffer D,
contained 40 ml of solubilized membranes, 0.16 mM dithiothreitol in the
absence or presence of 5000 U Endo H or 2500 U PNGase F. After incubation
at 37C for 3 hr, an equal volume of buffer E was added to each reaction and
incubated at 37C for 30 min. Samples were then subjected to 8% SDS/PAGE
and immunoblotted with monoclonal anti-FLAG antibody.
Immunoblot Analysis
Samples for immunoblotting were subjected to 8% or 13% SDS/PAGE, after
which the proteins were transferred to nitrocellulose filters. The immunoblots
were performed at room temperature using the following primary antibodies:
1 mg/ml mouse monoclonal anti-FLAG M2 (Sigma) and 1:3000 dilution of.
Cell Metabolism
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raised by injecting rabbits with a His10-tagged recombinant version of the
antigen. Bound antibodies were visualized by chemiluminescence (SuperSig-
nal West Pico Chemiluminescent Substrate, Thermo Scientific) using a 1:5000
dilution of anti-mouse IgG (Jackson ImmunoResearch Laboratories, Inc.) or
anti-rabbit IgG (GE Healthcare) conjugated to horseradish peroxidase. The
filters were exposed to Phenix Research Products Blue X-ray Film (F-BX810)
at room temperature.
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